Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (181-190 of 260) with videos related to

Pageof 26
Sort By:
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasmsJonathan Benjamin, Saurabh Chhabra, Holbrook E Kohrt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphomaLisa Y Law, Sandra J Horning, Ruby M Wong, et al.
Blood|September 1, 1994
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phaseD S Snyder, R S Negrin, M R O'Donnell, et al.
Blood|August 28, 2015
MLL leukemia induction by genome editing of human CD34+ hematopoietic cellsCorina Buechele, Erin H Breese, Dominik Schneidawind, et al.
Radiation Research|July 4, 2014
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusionAlexander Filatenkov, Jeanette Baker, Antonia M Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantationT M Cao, R S Negrin, K E Stockerl-Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's diseaseM J Stuart, N S Chao, S J Horning, et al.
Pageof 26

Showing results (181-190 of 260) with videos related to

Sort By:
Pageof 26
Blood|June 4, 2008
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimenGinna G Laport, Joseph C Alvarnas, Joycelynne M Palmer, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Blood|August 9, 2003
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaSteven M Horwitz, Robert S Negrin, Karl G Blume, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 11, 2014
Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasmsJonathan Benjamin, Saurabh Chhabra, Holbrook E Kohrt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphomaLisa Y Law, Sandra J Horning, Ruby M Wong, et al.
Blood|September 1, 1994
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phaseD S Snyder, R S Negrin, M R O'Donnell, et al.
Blood|August 28, 2015
MLL leukemia induction by genome editing of human CD34+ hematopoietic cellsCorina Buechele, Erin H Breese, Dominik Schneidawind, et al.
Radiation Research|July 4, 2014
Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusionAlexander Filatenkov, Jeanette Baker, Antonia M Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 5, 2000
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantationT M Cao, R S Negrin, K E Stockerl-Goldstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 5, 2002
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's diseaseM J Stuart, N S Chao, S J Horning, et al.
Pageof 26